# Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-pharmacokinetics-and-efficacy-of-donafenib-in-treating-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jingrui Liu,Xiaojiao Li,Hong Zhang,Guiling Chen,Hong Chen,Yue Hu,Junqi Niu,Yanhua Ding |
| Citations | 25 |
| DOI | 10.31083/ph.2019.9626 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://storage.imrpress.com/IMR/hmed/application/10.1691/ph.2019.9626.pdf |
| OpenAlex ID | https://openalex.org/W2990931063 |
| PMID | 31739839 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Xiaojiao Li](https://scholariq.org/researchers/xiaojiao-li/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.